Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
The highly-anticipated fifth edition is here! Get the must-have resource for achieving compliance with medical device regulations.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 10 May 2012 | By Louise Zornoza,
Brazil's reorganized national regulatory agency, Anvisa, said in remarks it is focused on establishing "a regulatory environment conducive to innovation."
The remarks, by Anvisa's CEO Dirceu Barbano, were made at the opening of the First Week of Sanitary Surveillance in Congress on 8 May.
The regulatory framework for innovation support will be based on "stability, predictability, clarity, rationality and efficiency," explained Barbano.
Innovation is a cornerstone of Brazil's ability to be competitive internationally, and Anvisa recently adopted new policies to facilitate bringing new clinical research into the country.
Anvisa - Health Surveillance in the development agenda
More Breaking News from RegLink
Tags: 2012, brazil, innovation, regulatory